Open Access
Blood Research articles are published open access under a CC BY licence (Creative Commons Attribution 4.0 International licence).
The CC BY licence is the most open licence available and considered the industry 'gold standard' for open access; it is also preferred by many funders. This licence allows readers to copy and redistribute the material in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited.
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
Young Hoon Park, Dae-Young Kim, Seongkoo Kim, Young Bae Choi, Dong-Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung-Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook, on behalf of Korean Aplastic Anemia Working Party
Blood Res 2022;57: 20-28 -
Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
Blood Res 2022;57: S79-S85
Most Cited
-
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res 2022;57: S32-S36 -
Overview of inherited bone marrow failure syndromes
Meerim Park
Blood Res 2022;57: S49-S54
Editorial Office
+82-2-516-6582
